Related Experiment Video
Updated: Jul 18, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation
1Department of Anatomy, College of Veterinary Medicine and Research Institute of Life Science, Gyeongsang National University, 900 Gajwa-dong, Jinju 660-701, South Korea. pokoh@gsnu.ac.kr
Neuroscience Letters
|January 2, 2007
Summary
Estradiol protects brain cells from injury by activating survival signals and inhibiting cell death pathways. This hormone reduces infarct volume and promotes neuronal survival through the Raf-MEK-ERK cascade.
Area of Science:
- Neuroscience
- Endocrinology
- Cell Biology
Background:
- Estradiol (estrogen) plays a role in neuroprotection.
- Brain injury, such as from stroke, triggers neuronal cell death.
- The specific molecular mechanisms of estradiol's neuroprotective effects require further elucidation.
Purpose of the Study:
- To investigate the role of estradiol in modulating anti-apoptotic signaling pathways.
- To determine if estradiol activates the Raf-MEK-ERK cascade and its downstream targets in the context of brain injury.
- To examine the effect of estradiol on neuronal survival and infarct volume following ischemic injury.
Main Methods:
- Ovariectomized adult female rats were subjected to middle cerebral artery occlusion (MCAO).
- Animals were treated with estradiol prior to MCAO.
- Brain tissues were collected 24 hours post-MCAO for analysis of infarct volume, TUNEL staining, and protein phosphorylation (Raf-1, MEK1/2, ERK1/2, p90RSK, Bad).
- Protein interactions between phospho-Bad and 14-3-3 were assessed.
Main Results:
- Estradiol treatment significantly reduced infarct volume and decreased TUNEL-positive cells in the cerebral cortex.
- Estradiol prevented the MCAO-induced decrease in phosphorylation of Raf-1, MEK1/2, and ERK1/2.
- Estradiol inhibited the injury-induced decrease in phosphorylation of p90RSK and Bad, and increased the interaction of phospho-Bad with 14-3-3.
Conclusions:
- Estradiol exerts significant neuroprotective effects against ischemic brain injury.
- The Raf-MEK-ERK signaling cascade and its downstream targets (p90RSK, Bad phosphorylation) are key mediators of estradiol's protective effects.
- Estradiol's ability to activate survival pathways and inhibit apoptosis contributes to reduced neuronal cell death and infarct volume.
Related Concept Videos
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...